NobleBlocks

Research indexJournal article

Клиническая эффективность вакцинации конъюгированной пневмококковой вакциной пациентов с хронической бронхолегочной патологией в Городском пульмонологическом центре Челябинска

Игнатова, Родионова

Пульмонология26 Sep 2014

NobleIDark:/48914/w1/20260515/92E6B943DOI10.18093/0869-0189-2013-0-6-739-750

Paywalled

The full text is at the publisher

You can read the abstract here, or open it at the publisher.

Read at the publisher

Abstract

Summary. Since November, 2012, patients with chronic lung disease, chronic heart failure (CHF) or a history of myocardial infarction have being actively vaccinated using 13-valent conjugated pneumococcal vaccine, in Chelyabinsk pulmonological centre. To December, 2013, 103 patients have been vaccinated. Safety of 13-valent conjugated pneumococcal vaccine was evaluated in all vaccinated patients. Efficacy was evaluated in 61 patients (21 with chronic obstructive pulmonary disease (COPD), 10 with bronchiectasis, 26 with COPD and asthma, and 4 with CHF. The vaccine efficacy was evaluated in a year after the vaccination. We found 4.8-fold reduction in exacerbation number in COPD patients, 4.1-fold reduction in bronchiectasis patients and 2.3-fold reduction in patients with COPD and asthma. Number of hospitalisations decreased in 9, 8 и 2.2 times, respectively; number of pneumonias decreased in 6; 4.1 and 2.3 times, respectively.

Discussion

Citations

Topics

More

Suggest a correction or report